← All organizations

Institute for Clinical Research

Academic/Hospital

Also known as: Institute for Clinical Research

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

favipiravir

Phase 2 (1 own, 0 via acquisition)

fam-trastuzumab deruxtecan-nxki

Other trials (1 own, 0 via acquisition)

modafinil

Recent trials (4)

NCT06610825CollaboratorPhase 2Oct 31, 2024
NCT04818320CollaboratorPhase 3Feb 16, 2021
NCT00210301Overall official - principal investigatorN/AJan 1, 2003
NCT00210301Lead sponsorN/AJan 1, 2003

Details

Last known activity: Oct 31, 2024